Drugs / DS-2248
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01288430 | Mar 2011 → Feb 2014 | non-small cell lung carcinoma | Daiichi Sankyo | Terminated | No outcome recorded Stop: Business |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DS-2248 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01288430 ↗ |
| Action | Inhibit | “Heat Shock Protein 90 Inhibitor” NCT01288430 ↗ |
| Modality | Small molecule | — CHEMBL5095177 ↗ |
| Route | Oral | “The drug will be administered as oral capsules once daily” NCT01288430 ↗ |